A chemical called lactate, which your body makes during exercise, can help heart cells take in sugar by moving tiny sugar-carriers (called GLUT1 and GLUT4) to the cell's surface. Even when you block a specific cell signal (the PI3K pathway) with a drug, these carriers still get moved, so there must be another way the cells do it.
See the scientific wording
In rat hearts, lactate induces the translocation of glucose transporters GLUT1 and GLUT4 through a mechanism that is independent of the phosphatidylinositol-3-kinase (PI3K) signaling pathway, as demonstrated by the lack of inhibition of translocation upon treatment with the PI3K inhibitor wortmannin.
Correlational — new studies may shift this
ObservationalOne low-scoring study links this claim to the outcome, but causation is not established.
What the research says
1 study reviewedSupporting (1)
Cross-Sectional StudyAnimal2002
Lactate moves glucose transporters to the cell surface even when we block a specific signaling molecule (PI3K), so it uses a different pathway.
Contradicting (0)
No contradicting studies found yet
That doesn't mean it's settled — it just means no study has tested the opposite.
Quality-weighted scoring: we follow the GRADE framework — each study is rated High, Moderate, Low, or Very Low based on study design, methodology rigor, and risk of bias. A single high-quality RCT can outweigh several weaker observational studies.
Scores reflect study quality, not just count.
Lactate, a substance made when muscles work hard, sends a signal inside heart cells that moves glucose transporters (like little doors for sugar) from the inside of the cell to the outside surface. This happens even when we block a common cell signal (PI3K) that usually controls this movement, so it uses a different signal. The heart cells then have more doors on their surface, but they don't actually let more sugar in because another part of the process is also blocked.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting study
How Fit Body Science checks a claim
- 1
We isolate the claim
Health advice from videos, articles and studies is broken down into single, testable claims.
- 2
We find the research
Each claim is matched against peer-reviewed studies, with every source cited by DOI.
- 3
We grade the evidence
Studies are scored on methodology, statistical rigor, transparency and publication quality.
The fitness and health internet is full of confident claims. We check them against real research.
Every claim on this site is traced back to peer-reviewed studies, scored on methodology and reporting quality, and given a verdict you can audit yourself — sources, DOIs and all.
- Full evidence breakdown and mechanism chains
- Ask our AI anything about a claim or its studies
- Get notified when new research changes a verdict
A chemical called lactate, which your body makes during exercise, can help heart cells take in sugar by moving tiny sugar-carriers (called GLUT1 and GLUT4) to the cell's surface. Even when you block a specific cell signal (the PI3K pathway) with a drug, these carriers still get moved, so there must be another way the cells do it.
Mechanism
1 studyLactate tells heart cells to move sugar doors to the outside, and this works even when a common cell signal is blocked, so it uses a different signal. But even with more doors, the cells don't let more sugar in because another step is slowed down.
Lactate, a substance made when muscles work hard, sends a signal inside heart cells that moves glucose transporters (like little doors for sugar) from the inside of the cell to the outside surface. This happens even when we block a common cell signal (PI3K) that usually controls this movement, so it uses a different signal. The heart cells then have more doors on their surface, but they don't actually let more sugar in because another part of the process is also blocked.
Lactate enters the heart muscle cells and activates an as-yet-unknown signaling cascade within the cells.
This signaling cascade is independent of the PI3K pathway, as demonstrated by the lack of inhibition when PI3K is blocked with wortmannin.
The cascade promotes the movement of vesicles containing GLUT1 and GLUT4 from intracellular storage to the plasma membrane, increasing the number of glucose transporters on the cell surface.
Despite the increased presence of glucose transporters on the surface, the phosphorylation and uptake of glucose analogues is reduced, indicating that downstream glucose phosphorylation is inhibited, so glucose uptake does not increase.
Evidence from Studies
Supporting (1)
Community contributions welcome
Lactate-induced translocation of GLUT1 and GLUT4 is not mediated by the phosphatidylinositol-3-kinase pathway in the rat heart
Lactate moves glucose transporters to the cell surface even when we block a specific signaling molecule (PI3K), so it uses a different pathway.
Contradicting (0)
Community contributions welcome
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Systematic Review of Animal Studies on Lactate-Induced GLUT Translocation and PI3K Independence
Comprehensive search of databases for peer-reviewed animal studies (rat or other mammalian models) that examined lactate's effect on GLUT1/GLUT4 translocation with and without PI3K inhibitors (e.g., wortmannin, LY294002), followed by meta-analysis if feasible.
Randomized Controlled Trial in Rat Hearts: Lactate Infusion with or without Wortmannin to Assess GLUT1/GLUT4 Membrane Translocation
Randomized, controlled animal trial: adult rats randomized to receive lactate infusion + vehicle, lactate + wortmannin, or control (no lactate). Hearts harvested and GLUT1/GLUT4 membrane fractions measured by Western blot or immunofluorescence. Blinded analysis, adequate sample size, and predetermined endpoints.
Controlled Experimental Study in Isolated Perfused Rat Hearts: Effect of Wortmannin on Lactate-Stimulated Glucose Transporter Translocation
Langendorff-perfused rat hearts treated with lactate in the presence or absence of wortmannin; measure sarcolemmal GLUT1 and GLUT4 levels via subcellular fractionation and Western blotting. Include negative controls and dose-response of wortmannin.